Compare MGTX & ARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGTX | ARI |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 884.4M |
| IPO Year | 2018 | 2009 |
| Metric | MGTX | ARI |
|---|---|---|
| Price | $10.89 | $6.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $27.75 | $8.00 |
| AVG Volume (30 Days) | 932.9K | ★ 2.6M |
| Earning Date | 11-12-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 16.05% |
| EPS Growth | 33.02 | ★ 183.51 |
| EPS | ★ 1.30 | 0.27 |
| Revenue | $81,391,000.00 | ★ $271,589,000.00 |
| Revenue This Year | $314.19 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $8.40 | $23.07 |
| Revenue Growth | ★ 144.57 | N/A |
| 52 Week Low | $6.62 | $6.11 |
| 52 Week High | $15.35 | $11.24 |
| Indicator | MGTX | ARI |
|---|---|---|
| Relative Strength Index (RSI) | 31.37 | 27.37 |
| Support Level | $8.84 | N/A |
| Resistance Level | $11.85 | $7.00 |
| Average True Range (ATR) | 0.58 | 0.11 |
| MACD | -0.18 | 0.01 |
| Stochastic Oscillator | 13.29 | 20.41 |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
Apollo Commercial Real Estate Finance Inc is a real estate investment trust that originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.